Lung Cancer Trial, Recruiting (NCT06869447)

Lung Cancer Trial, Recruiting NCT06869447 Sponsor: Roswell Park Cancer Institute Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06869447 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You can speak, read, and understand English
You identify as non-Hispanic Black or non-Hispanic White
You were diagnosed with invasive lung cancer (that has not spread to other parts of the body) within the last 24 months, confirmed by a tissue test
You have had surgery for your lung cancer (mainly for stage I, II, or III) and have finished all cancer treatments, including surgery, chemotherapy, and radiation
You are willing to give a blood sample, which would be collected at your home by a visiting blood draw service
You are willing to sign a consent form showing you understand the nature of the study before taking part

Who may not be able to join:

Your cancer was diagnosed as stage 0 (very early, non-invasive) or stage IV (has spread to other parts of the body)
You have certain health conditions that make breathing muscle exercises unsafe for you, such as a recent blood clot in the lungs, an aortic aneurysm, or a current collapsed lung (confirm with trial site)
You are already regularly following a structured exercise program or currently meeting general exercise guidelines
You are unwilling or unable to follow the study's requirements
The trial doctor believes, for any reason, that you are not a suitable candidate for the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06869447

Sponsor: Roswell Park Cancer Institute

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT06869447

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You can speak, read, and understand English
You identify as non-Hispanic Black or non-Hispanic White
You were diagnosed with invasive lung cancer (that has not spread to other parts of the body) within the last 24 months, confirmed by a tissue test
You have had surgery for your lung cancer (mainly for stage I, II, or III) and have finished all cancer treatments, including surgery, chemotherapy, and radiation
You are willing to give a blood sample, which would be collected at your home by a visiting blood draw service
You are willing to sign a consent form showing you understand the nature of the study before taking part

Who may not be able to join:

Your cancer was diagnosed as stage 0 (very early, non-invasive) or stage IV (has spread to other parts of the body)
You have certain health conditions that make breathing muscle exercises unsafe for you, such as a recent blood clot in the lungs, an aortic aneurysm, or a current collapsed lung (confirm with trial site)
You are already regularly following a structured exercise program or currently meeting general exercise guidelines
You are unwilling or unable to follow the study's requirements
The trial doctor believes, for any reason, that you are not a suitable candidate for the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Roswell Park Cancer Institute

Registry

ClinicalTrials.gov

Start date

20 April 2026

Est. completion

15 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percentage of patients who complete at least 3 respiratory muscle training (RMT) sessions/week (Compliance) (Aim 1); Proportion of planned sessions completed (Adherence) (Aim 1); Proportion of total completed to total planned cumulative dose (Tolerability) (Aim 1); Inspiratory muscle strength (Aim 2); Change in dyspnea (Aim 2)-Dyspnea-12 survey; Change in dyspena (Aim 2)- Functional Assessment of Chronic Illness Therapy (FACIT) dyspnea; Change in cancer-related fatigue (Aim 2) - Brief Fatigue Inventory; Change in cancer related Fatigue (Aim 2) - FACIT fatigue scale; Circulating levels of myelo...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov